SAN DIEGO, April 22, 2021 /PRNewswire/ -- Evofem
Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and
conference call to discuss the Company's financial results and
business highlights for the first quarter ended March 31,
2021 as follows:
Date
|
Thursday, May 6,
2021
|
Time
|
4:30 p.m. ET (1:30
p.m. PT)
|
Webcast (live and
archived)
|
www.evofem.com under
"Investors"
|
Dial-in
numbers
|
(866) 503-5561 (U.S.
toll-free) or (253) 336-2965
|
Conference
ID
|
1899453
|
The live webcast and related slide presentation can be accessed
through the Investors section of its website or directly
at https://evofem.investorroom.com/2021Q1Results. Please connect to
the Company's website at least 15 minutes prior to the start of the
call to download any software that may be required. If
participating by phone, please dial in approximately 15 minutes
prior to the start of the call.
The webcast will be
archived at https://evofem.investorroom.com/2021Q1Results.
A telephone replay will be available for 24 hours after the
call at (855) 859-2056 (U.S.) or (404) 537-3406
(International), conference ID 1899453.
About Evofem Biosciences
Evofem Biosciences,
Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical
company committed to developing and commercializing
innovative products to address unmet needs in women's sexual
and reproductive health, including hormone-free, woman-controlled
contraception and protection from certain sexually transmitted
infections (STIs). The Company launched its first FDA-approved
commercial product, Phexxi® contraceptive vaginal gel,
in the United States in September 2020. Evofem's
lead product candidate, EVO100, is being evaluated for the
prevention of urogenital Chlamydia trachomatis and
Neisseria gonorrhoeae infection in women in the ongoing
Phase 3 clinical trial, 'EVOGUARD.' For more information,
please visit evofem.com.
Phexxi® is a registered trademark of Evofem
Biosciences, Inc.
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-first-quarter-2021-results-and-provide-corporate-update-on-thursday-may-6-2021-301274348.html
SOURCE Evofem Biosciences, Inc.